Keyphrases
Medication Effects
100%
Urethral Sphincter
100%
Pressure-flow Study
100%
Concentric Needle Electromyography
100%
Neuromuscular Function
75%
Current Perception Threshold
75%
Urethral Sensation
75%
Pseudoephedrine
75%
Placebo
50%
Lower Urinary Tract Symptoms
50%
Tamsulosin
50%
Imipramine
50%
Threshold Test
50%
Solifenacin
50%
Cyclobenzaprine
50%
Postmenopausal Women
25%
African American
25%
Action Potential
25%
Urodynamics
25%
Body Mass Index
25%
Physiological Effects
25%
Stimulus Intensity
25%
No Significant Difference
25%
Medication Therapy
25%
Pre-post Change
25%
Nonparametric Test
25%
Baseline Testing
25%
Multi-motor
25%
Threshold Flux
25%
Unit Action
25%
Medicine and Dentistry
Sphincter
100%
Sensation
100%
Electromyography
80%
Neuromuscular Function
60%
Perceptive Threshold
60%
Pseudoephedrine
60%
Lower Urinary Tract Symptom
40%
Imipramine
40%
Placebo
40%
Cyclobenzaprine
40%
Body Mass Index
20%
Premenopause
20%
Nonparametric Test
20%
Solifenacin Plus Tamsulosin
20%
Urodynamics
20%
Tamsulosin
20%
Action Potential
20%
Solifenacin
20%
Nursing and Health Professions
Electromyography
100%
Pseudoephedrine
75%
Perceptive Threshold
75%
Placebo
50%
Lower Urinary Tract Symptom
50%
Imipramine
50%
Cyclobenzaprine
50%
Body Mass
25%
Tamsulosin
25%
Solifenacin
25%
Solifenacin Plus Tamsulosin
25%
Action Potential
25%
Nonparametric Test
25%
Neuroscience
Electromyography
100%
Pseudoephedrine
75%
Neuromuscular Function
75%
Imipramine
50%
Solifenacin
50%
Placebo
50%
Tamsulosin
50%
Cyclobenzaprine
50%
Body Mass Index
25%
Action Potential
25%